pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
Leyla Blanco-García(Research Institute Hospital 12 de Octubre), José Luis Rodríguez‐Peralto(Research Institute Hospital 12 de Octubre)
Cited by 7
Related Papers
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases
|Histopathology|2009|120